Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

LAB

Standard BioTools (LAB)

Standard BioTools Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LAB
DateTimeSourceHeadlineSymbolCompany
03/04/20256:46PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:LABStandard BioTools Inc
03/04/20254:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
03/04/20254:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
02/27/20253:01PMGlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
02/26/20253:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
02/26/20253:01PMGlobeNewswire Inc.Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
02/24/20254:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
02/12/20256:00AMGlobeNewswire Inc.Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025NASDAQ:LABStandard BioTools Inc
01/13/20256:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
01/13/20256:00AMGlobeNewswire Inc.Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 RevenueNASDAQ:LABStandard BioTools Inc
01/10/20253:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
01/08/20256:00AMGlobeNewswire Inc.Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature MedicineNASDAQ:LABStandard BioTools Inc
12/20/20243:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
12/19/20247:00AMGlobeNewswire Inc.Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LABStandard BioTools Inc
11/21/20247:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
11/14/20242:32PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LABStandard BioTools Inc
11/12/20243:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LABStandard BioTools Inc
11/07/20247:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
11/07/20247:00AMGlobeNewswire Inc.Standard BioTools Appoints Alex Kim as Chief Financial OfficerNASDAQ:LABStandard BioTools Inc
11/06/20244:17PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABStandard BioTools Inc
10/31/20247:01AMGlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
10/30/20243:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
10/30/20243:01PMGlobeNewswire Inc.Standard BioTools Reports Third Quarter 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
10/24/20241:02PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:LABStandard BioTools Inc
10/21/20243:26PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LABStandard BioTools Inc
10/16/20247:00AMGlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024NASDAQ:LABStandard BioTools Inc
09/24/20247:00AMGlobeNewswire Inc.Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K PlatformNASDAQ:LABStandard BioTools Inc
09/18/20247:00AMGlobeNewswire Inc.Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)NASDAQ:LABStandard BioTools Inc
09/09/20242:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LABStandard BioTools Inc
09/05/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
 Showing the most relevant articles for your search:NASDAQ:LAB